Navigation Links
Solutions Being Sought For Prevention Of Rickets

For years, doctors thought of rickets as a disease of the past. New research shows it should still be considered a problem and prevention should // start before birth and researchers suggest pregnant women should be given vitamin D supplementation.

Rickets is a childhood disorder involving softening and weakening of the bones, primarily caused by lack of vitamin D, calcium, or phosphate. It is most likely to occur during rapid growth, when the body demands high levels of calcium and phosphate. Rickets may be seen in young children 6 to 24 months old.

Doctors say rickets is increasing for two main reasons. They say more babies are being breastfed longer, with no vitamin D supplementation and children and mothers get less sun exposure because of concerns about skin cancer. Doctors also indicate immigrant groups have a higher prevalence of rickets.

Researchers suggest pregnant women (living outside the tropics) in the second and third trimesters should receive a supplement of 400 IU to1000 IU daily and Exclusively breastfed children of Asian and black mothers living outside the tropics should receive 280 to 400 IU. They recommend vitamin D supplements be given to children until the growth spurt that accompanies puberty is finished. Moderate sun exposure will also help.
'"/>




Page: 1

Related medicine news :

1. Mental Hospitals Offer More Problems than Solutions
2. Sex Workers Adopt IT Solutions to Fight AIDS
3. Bilcare Signs Pact With Honeywell for Packaging Solutions
4. Simple Solutions to Postpartum Weight Retention
5. Solutions Possible for Providing Water and Sanitation in Poor Urban Settlements, Says WaterAid
6. Overweight Kids At Risk Of Being Iron Deficient
7. Being Overweight Could Lead To Irregular Heartbeats
8. Being Obese Increases Ones Risk Of A wrong Diagnosis During Medical Imaging
9. Being Obese Could Lead To Kidney Stone Formation
10. Patients Suffering From Severe Mental Diseases Are At Risk Of Being Crime Victims
11. Being together matters, both in marriage and smoking
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... 24, 2016 , ... Puradigm® & Innovative Solutions today announced ... and processing operations at its production facility, and opened its first two dispensaries ... manufacturer of a complete system of proactive air and surface purification solutions for ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: